Emedrotec Bioadhesive Tablets; the unique entry to the Egyptian market December 2, 2009

Emedrotec Bioadhesive Tablets; the unique entry to the Egyptian market

 

 

 

 

 

 

 

Nausea and/or vomiting are common complaints that can be related to several conditions; gastroenteritis, vertigo and motion sickness, migraine, chemotherapy and radiation, surgical operations and anesthesia.

 

Eva Pharma has formulated a unique buccalbioadhesive dosage in the form of Emedrotec tablets (Prochlorperazine) to treat nausea and/or vomiting, bringing this product to the Egypt for the first time.

 

Upon taking the tablet, patients will be able to gain different advantages from the Emedrotec bioadhesive tablets, ranging from the faster relief of nausea and vomiting, the convenience of avoiding injection pain and the ensured effect of the drug even during current vomiting episodes.